Strategic Collaboration Is Key to Innovation for Sorin Group, LivaNova, Nipro
Prevalence of cardiovascular disorders is increasing over the time, in turn fostering the demand for various related products, services, and solutions on a global level. During a cardiac surgery, a cardiopulmonary bypass system is temporarily employed to take over the heart and lungs in terms of function. It aids in maintenance of healthy blood circulation and oxygen flow throughout the body. Cardiopulmonary bypass systems are the most sought after in an open heart surgery, as it performs the function of both heart and lung. Frequent product launches and increasing innovations are expected to boost the growth of global cardiopulmonary bypass systems market.
The market is flooded with a number of active companies, including Sorin Group, Braile Biomedica, Transonic, Spectrum Medical, Minnetronix, Inc., Medtronic Plc., MAQUET Holding B.V. & Co. KG., Getinge AB, LivaNova PLC, Terumo Corporation, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets Srl, OriGen Biomedical, and Thoratec Corporation. Most of the key companies are focusing more on mergers, acquisitions, and sytrategic collaborations so as to retain higher market shares.
Sorin Group and Cybertronics combined to form a new global company
Sorin Group, one of the leading market players, decided to merge with Cyberonics Inc. in 2015, forming a brand new medical technology company – LivaNova. This transaction was aimed at bringing together all the global leaders operating the industry of cardiac surgery and neuromodulators.
LivaNova’s acquisition of TandemLife to extend its portfolio
LivaNova recently announced its plan to acquire TandemLife, a leading medical device company. This acquisition has been effective with an agenda to add a range of advanced cardiopulmonary temporary support solutions to the existing portfolio of LivaNova.
MicroPort foresees bright future in medical devices industry
MicroPort Scientific, a company that has successfully captured Indian market with a cardiovascular stents range, now plans to foray in the Indian market for orthopedic implants. The company already boasts of a globally recognized extensive product range and this new venture is likely to turn into a major step towards grabbing the position as a key player in the medical devices industry in developing regions within Asia, especially India.
Japan’s Nipro Corp. aspires to develop an immunotherapy product
Nipro Corporation recently announced a strategic collaboration with a leading Scottish firm, TC BioPharm in an effort to co-produce a novel product to be used in immunotherapy that selectively targets cancerous cells and leaves healthy cells untouched and intact. This could be a revolutionary development in the medical world. For co-development of the desired product, TC BioPharm’s safe CAR-T platform will be used and the company will possibly utilize this platform in treatment of cancers as well as viral diseases.
Despite innovations and collaborative activities by leading and emerging players, the global market for cardiopulmonary bypass systems is anticipated to witness challenging scenarios due to stringent regulatory standards for cardiopulmonary bypass systems and possible adverse effects of bypass procedures.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5855